共 211 条
- [1] Bhatt DL(2006)International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis JAMA 295 180-189
- [2] Steg PG(2020)Major cardiovascular and bleeding events with long-term use of aspirin in patients with prior cardiovascular diseases: 1-year follow-up results from the Management of Aspirin-induced Gastrointestinal Complications (MAGIC) study Heart Vessels 35 170-176
- [3] Ohman EM(2011)One-year cardiovascular event rates in Japanese outpatients with myocardial infarction, stroke, and atrial fibrillation. Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE) Circ J 75 2598-2604
- [4] Uchiyama S(2017)Real-world setting comparison of nonvitamin-K antagonist oral anticoagulants versus vitamin-K antagonists for stroke prevention in atrial fibrillation: a systematic review and meta-analysis Stroke 48 2494-2503
- [5] Goto S(2015)Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs Lancet 386 303-310
- [6] Origasa H(2015)Stroke prevention in atrial fibrillation: a systematic review JAMA 313 1950-1962
- [7] Goto S(2010)Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2369-2429
- [8] Ikeda Y(2014)2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 64 e1-e76
- [9] Shimada K(2019)Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE registry Thromb Haemost 119 319-327
- [10] Uchiyama S(2016)Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation J Thromb Thrombolysis 42 573-578